Kentucky Retirement Systems Has $1.81 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Kentucky Retirement Systems lessened its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 2.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,489 shares of the medical instruments supplier’s stock after selling 130 shares during the period. Kentucky Retirement Systems’ holdings in West Pharmaceutical Services were worth $1,808,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Artisan Partners Limited Partnership raised its stake in shares of West Pharmaceutical Services by 23.2% during the 4th quarter. Artisan Partners Limited Partnership now owns 1,961,063 shares of the medical instruments supplier’s stock worth $690,530,000 after purchasing an additional 369,792 shares in the last quarter. APG Asset Management US Inc. bought a new stake in West Pharmaceutical Services during the fourth quarter worth $88,227,000. LGT Group Foundation bought a new stake in West Pharmaceutical Services during the second quarter worth $68,854,000. Liontrust Investment Partners LLP acquired a new stake in West Pharmaceutical Services in the second quarter valued at $64,196,000. Finally, TD Asset Management Inc grew its position in shares of West Pharmaceutical Services by 38.4% in the 4th quarter. TD Asset Management Inc now owns 659,560 shares of the medical instruments supplier’s stock valued at $232,244,000 after acquiring an additional 183,153 shares during the period. 93.90% of the stock is owned by institutional investors and hedge funds.

West Pharmaceutical Services Trading Down 1.0 %

West Pharmaceutical Services stock opened at $308.15 on Friday. The stock has a 50-day simple moving average of $303.67 and a 200 day simple moving average of $337.77. The stock has a market capitalization of $22.45 billion, a P/E ratio of 40.65, a PEG ratio of 10.58 and a beta of 1.01. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.68 and a current ratio of 2.34. West Pharmaceutical Services, Inc. has a 52 week low of $265.00 and a 52 week high of $413.70.

West Pharmaceutical Services (NYSE:WST) last issued its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 EPS for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The business had revenue of $702.10 million for the quarter, compared to the consensus estimate of $729.36 million. During the same quarter in the prior year, the firm posted $2.11 earnings per share. The business’s revenue was down 6.9% compared to the same quarter last year. Analysts expect that West Pharmaceutical Services, Inc. will post 6.42 earnings per share for the current year.

Insider Buying and Selling at West Pharmaceutical Services

In other news, VP Charles Witherspoon sold 1,029 shares of the firm’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $300.00, for a total transaction of $308,700.00. Following the completion of the sale, the vice president now owns 1,478 shares in the company, valued at approximately $443,400. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.